Santhera Pharmaceuticals is a specialized Swiss biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines focusing on rare neuromuscular and pulmonary diseases with high unmet medical needs. The company leverages specialized scientific research to advance treatments for rare conditions, working closely with regulatory health authorities to bring specialized therapies to patients across global markets.